Upstream Bio (UPB) Amortizatization of Intangibles (2023 - 2026)
Upstream Bio (UPB) recorded quarterly Amortizatization of Intangibles of $754000.0 in Q1 2026, up 154.96% quarter-over-quarter from -$1.4 million in Q4 2025, and down 56.54% on a YoY basis from $1.7 million in Q1 2025.
Upstream Bio (UPB) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Upstream Bio's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $754000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 56.54% year-over-year to $754000.0; the TTM figure through Mar 2026 stood at $521000.0 (down 81.17% YoY), while the FY2025 annual figure was $1.5 million, down 9.24% from the prior year.
- Amortizatization of Intangibles was $754000.0 for Q1 2026 at Upstream Bio, up from -$1.4 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q1 2025 to a low of -$1.4 million in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $415900.0 across 4 years, with a median of $597500.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles tumbled 375.0% in 2024, then surged 178.49% in 2025.
- A 4-year view of Amortizatization of Intangibles shows it stood at $248000.0 in 2023, then sank by 375.0% to -$682000.0 in 2024, then slumped by 101.17% to -$1.4 million in 2025, then jumped by 154.96% to $754000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $754000.0 (Q1 2026), -$1.4 million (Q4 2025), and $154000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn | 754,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 754,000.00 |
| Mar 31, 2026 | 754,000.00 |
| Dec 31, 2025 | -1.37 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | 154,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 985,000.00 |
| Jun 30, 2025 | 985,000.00 |
| Mar 31, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | -682,000.00 |
| Dec 31, 2024 | -682,000.00 |
| Sep 30, 2024 | 572,000.00 |
| Sep 30, 2024 | 572,000.00 |
| Jun 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 623,000.00 |
| Mar 31, 2024 | 623,000.00 |
| Dec 31, 2023 | 248,000.00 |
| Dec 31, 2023 | 248,000.00 |